No CrossRef data available.
Article contents
Major Depressive Disorder: Barriers to Treatment
Published online by Cambridge University Press: 07 November 2014
Extract
There are a variety of barriers to major depressive disorder (MDD) treatment which may impede access to professional help and prevent best patient outcome. These barriers include the heterogeneity of MDD, societal factors, and clinician-patient relationship as well as issues of concordance, compliance, and adherence.
- Type
- Expert Panel Supplement
- Information
- Copyright
- Copyright © Cambridge University Press 2009
References
1.Diagnostic and Statistical Manual of Mental Disorders. 4th ed.Washington, DC: American Psychiatric Association; 1994.Google Scholar
2.Cassano, P, Fava, M. Depression and public health: an overview. J Psychosom Res. 2002;53(4):849–857.CrossRefGoogle Scholar
3.Kessler, RC, Berglund, P, Demler, O, et al, and the National Comorbidity Survey Replication. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289(23):3095–3105.CrossRefGoogle ScholarPubMed
4.Shelton, RC. Mood-stabilizing drugs in depression. J Clin Psychiatry. 1999;60(suppl 5):37–40.Google ScholarPubMed
5.Wang, PS, Berglund, P, Olfson, M, Pincus, HA, Wells, KB, Kessler, RC. Failure and delay in initial treatment contact after first onset of mental disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):603–613.CrossRefGoogle ScholarPubMed
6.Fisher, R, Ury, WL, Patton, BM. Getting to Yes: Negotiating Agreement Without Giving In. 2nd ed.New York, NY: Penguin Books; 1991.Google Scholar
7.Katz, J. The Silent World of Doctor and Patient. Baltimore, MD: The Johns Hopkins University Press; 2002.CrossRefGoogle Scholar
8.Schneider, CE. The Practice of Autonomy: Patients, Doctors, and Medical Decisions. New York, NY: Oxford University Press; 1998.CrossRefGoogle Scholar
9.Nierenberg, AA, Ostacher, MJ, Borrelli, DJ, et al. The integration of measurement and management for the treatment of bipolar disorder: a STEP-BD model of collaborative care in psychiatry. J Clin Psychiatry. 2006;67(suppl 11):3–7.Google ScholarPubMed
10.Lavori, PW, Keller, MB, Mueller, TI, Scheftner, W. Recurrence after recovery in unipolar MDD: an observational follow-up study of clinical predictors and somatic treatment as a mediating factor. Int J Meth Psychiatr Res. 1994;4:211–229.Google Scholar
11.McManus, P, Mant, A, Mitchell, P, Dudley, J. Length of therapy with selective serotonin reuptake inhibitors and tricyclic antidepressants in Australia. Aust N Z J Psychiatry. 2004;38(6):450–454.CrossRefGoogle ScholarPubMed
12.Haynes, RB, Sackett, DL, Guyatt, GH, Tugwell, P. Clinical Epidemiology: How to Do Clinical Practice Research. 2nd ed.Boston, MA: Little, Brown and Company; 1991.Google Scholar
13.Conrad, P. The meaning of medications: another look at compliance. Soc Sci Med. 1985;20(1):29–37.CrossRefGoogle Scholar
14.Simon, GE, VonKorff, M, Wagner, EH, Barlow, W. Patterns of antidepressant use in community practice. Gen Hosp Psychiatry. 1993;15(6):399–408.CrossRefGoogle ScholarPubMed
15.Lin, EH, Von Korff, M, Katon, W, et al. The role of the primary care physician in patients’ adherence to antidepressant therapy. Med Care. 1995;33(1):67–74.CrossRefGoogle ScholarPubMed
16.Katon, W, Von Korff, M, Lin, E, et al. Collaborative management to achieve treatment guidelines. Impact on depression in primary care. JAMA. JAMA. 1995;273(13):1026–1031.CrossRefGoogle Scholar
17.Keller, MB, Lavori, PW, Klerman, GL, et al. Low levels and lack of predictors of somatotherapy and psychotherapy received by depressed patients. Arch Gen Psychiatry. 1986;43(5):458–466.CrossRefGoogle ScholarPubMed
18.Mueller, TI, Keller, MB, Leon, AC, et al. Recovery after 5 years of unremitting major depressive disorder. Arch Gen Psychiatry. 1996;53(9):794–799.CrossRefGoogle ScholarPubMed